Danaher | DHR - SCHULD





SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
Agilent USD 3.35B 0 2025-12
Align Technology USD 114.45M 6.82M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Charles River Laboratories USD 2.57B 58.23M 2025-12
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.33B 137M 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
ESCO Technologies USD 188.98M 41.43M 2025-12
Fortive USD 3.21B 100.3M 2025-12
Henry Schein USD 3.75B 313M 2026-03
Illumina USD 2.55B 23M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 15.83B 109M 2026-03
Keysight Technologies USD 2.53B 3M 2026-03
Laboratory Of America USD 6.53B 3.9M 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Mettler Toledo International USD 2.15B 57.69M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Quest Diagnostics USD 6.41B 179M 2026-03
Quidel USD 2.83B 9.9M 2025-12
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 3.4B 29.2M 2025-12
Roper Industries USD 9.35B 104.8M 2025-12
Stryker USD 14.22B 635M 2026-03
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Waters USD 1.49B 4.92M 2025-12
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03